Lee S Cohen

Array ( [id] => 7026781 [patent_doc_number] => 20050020590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'P-38 kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/898581 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14424 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020590.pdf [firstpage_image] =>[orig_patent_app_number] => 10898581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5620270 [patent_doc_number] => 20060189804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Synthetic method for the preparation of quinazolin-4-one derivative' [patent_app_type] => utility [patent_app_number] => 10/562112 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189804.pdf [firstpage_image] =>[orig_patent_app_number] => 10562112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330090 [patent_doc_number] => 20040254203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Methods and compositions utilizing quinazolinones' [patent_app_type] => new [patent_app_number] => 10/893929 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 90 [patent_no_of_words] => 13673 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254203.pdf [firstpage_image] =>[orig_patent_app_number] => 10893929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910422 [patent_doc_number] => 07329664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues' [patent_app_type] => utility [patent_app_number] => 10/892741 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25019 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329664.pdf [firstpage_image] =>[orig_patent_app_number] => 10892741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972306 [patent_doc_number] => 20050038016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/884768 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38598 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038016.pdf [firstpage_image] =>[orig_patent_app_number] => 10884768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180830 [patent_doc_number] => 20050124607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => '5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/884595 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25928 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124607.pdf [firstpage_image] =>[orig_patent_app_number] => 10884595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991522 [patent_doc_number] => 20050090559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 10/882103 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32932 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090559.pdf [firstpage_image] =>[orig_patent_app_number] => 10882103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 526613 [patent_doc_number] => 07183274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-27 [patent_title] => 'Piperidine-2,6-diones heterocyclically substituted in the 3-position' [patent_app_type] => utility [patent_app_number] => 10/871522 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7286 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/183/07183274.pdf [firstpage_image] =>[orig_patent_app_number] => 10871522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817167 [patent_doc_number] => 07410975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Small molecule toll-like receptor (TLR) antagonists' [patent_app_type] => utility [patent_app_number] => 10/872196 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 36769 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410975.pdf [firstpage_image] =>[orig_patent_app_number] => 10872196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 566818 [patent_doc_number] => 07465738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Compounds useful as promoters of SMN2' [patent_app_type] => utility [patent_app_number] => 10/869498 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16603 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465738.pdf [firstpage_image] =>[orig_patent_app_number] => 10869498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673027 [patent_doc_number] => 20060178382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Chinazoline derivatives as aurora kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/560659 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27705 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178382.pdf [firstpage_image] =>[orig_patent_app_number] => 10560659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972341 [patent_doc_number] => 20050038051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Novel molecules for regulating cell death' [patent_app_type] => utility [patent_app_number] => 10/865542 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16947 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038051.pdf [firstpage_image] =>[orig_patent_app_number] => 10865542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200698 [patent_doc_number] => 20050165035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 10/857342 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16088 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165035.pdf [firstpage_image] =>[orig_patent_app_number] => 10857342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649806 [patent_doc_number] => 20060135541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => '(3-((Quinazolin-4-yl) amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer' [patent_app_type] => utility [patent_app_number] => 10/559328 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20831 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135541.pdf [firstpage_image] =>[orig_patent_app_number] => 10559328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127918 [patent_doc_number] => 20050059662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Substituted quinazolinone compounds' [patent_app_type] => utility [patent_app_number] => 10/850967 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57386 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059662.pdf [firstpage_image] =>[orig_patent_app_number] => 10850967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247117 [patent_doc_number] => 07585869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Substituted heterocylces for the treatment of abnormal cell growth' [patent_app_type] => utility [patent_app_number] => 10/849707 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32910 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585869.pdf [firstpage_image] =>[orig_patent_app_number] => 10849707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427577 [patent_doc_number] => 20040229897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Amide substituted imidazoquinolines' [patent_app_type] => new [patent_app_number] => 10/848893 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37733 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229897.pdf [firstpage_image] =>[orig_patent_app_number] => 10848893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233348 [patent_doc_number] => 20050256087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Phosphonic acid diester compounds' [patent_app_type] => utility [patent_app_number] => 10/838297 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20577 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256087.pdf [firstpage_image] =>[orig_patent_app_number] => 10838297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609482 [patent_doc_number] => 07994182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect' [patent_app_type] => utility [patent_app_number] => 10/554749 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 22 [patent_no_of_words] => 5923 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994182.pdf [firstpage_image] =>[orig_patent_app_number] => 10554749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089704 [patent_doc_number] => 20050009817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Substituted heteroaryls' [patent_app_type] => utility [patent_app_number] => 10/836371 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29823 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009817.pdf [firstpage_image] =>[orig_patent_app_number] => 10836371 [rel_patent_id] =>[rel_patent_doc_number] =>)